#BEGIN_DRUGCARD DB02127

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C7H17O3P

# Chemical_IUPAC_Name:
bis(propan-2-yl) methylphosphonate

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Methylphosphonic Acid Diisopropyl Ester

# HET_ID:
DII

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H17O3P/c1-6(2)9-11(5,8)10-7(3)4/h6-7H,1-5H3

# InChI_Key:
InChIKey=WOAFDHWYKSOANX-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2127

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
180.1818

# Molecular_Weight_Mono:
180.091530922

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1EZ2

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.02

# Predicted_LogS:
-1.1

# Predicted_Water_Solubility:
1.28e+01 g/l

# Primary_Accession_No:
DB02127

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
3073

# PubChem_Substance_ID:
46507529

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01207

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(C)OP(C)(=O)OC(C)C

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:49 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cell membrane
peripheral membrane protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M29593

# Drug_Target_1_GenBank_ID_Protein:
148713

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
opd

# Drug_Target_1_Gene_Sequence:
>1098 bp
ATGCAAACGAGAAGGGTTGTGCTCAAGTCTGCGGCCGCCGCAGGAACTCTGCTCGGCGGC
CTGGCTGGGTGCGCGAGCGTGGCTGGATCGATCGGCACAGGCGATCGGATCAATACCGTG
CGCGGTCCTATCACAATCTCTGAAGCGGGTTTCACACTGACTCACGAGCACATCTGCGGC
AGCTCGGCAGGATTCTTGCGTGCTTGGCCAGAGTTCTTCGGTAGCCGCAAAGCTCTAGCG
GAAAAGGCTGTGAGAGGATTGCGCCGCGCCAGAGCGGCTGGCGTGCGAACGATTGTCGAT
GTGTCGACTTTCGATATCGGTCGCGACGTCAGTTTATTGGCCGAGGTTTCGCGGGCTGCC
GACGTTCATATCGTGGCGGCGACCGGCTTGTGGTTCGACCCGCCACTTTCGATGCGATTG
AGGAGTGTAGAGGAACTCACACAGTTCTTCCTGCGTGAGATTCAATATGGCATCGAAGAC
ACCGGAATTAGGGCGGGCATTATCAAGGTCGCGACCACAGGCAAGGCGACCCCCTTTCAG
GAGTTAGTGTTAAAGGCGGCCGCCCGGGCCAGCTTGGCCACCGGTGTTCCGGTAACCACT
CACACGGCAGCAAGTCAGCGCGATGGTGAGCAGCAGGCCGCCATTTTTGAGTCCGAAGGC
TTGAGCCCCTCACGGGTTTGTATTGGTCACAGCGATGATACTGACGATTTGAGCTATCTC
ACCGCCCTCGCTGCGCGCGGATACCTCATCGGTCTAGACCACATCCCGCACAGTGCGATT
GGTCTAGAAGATAATGCGAGTGCATCAGCCCTCCTGGGCATCCGTTCGTGGCAAACACGG
GCTCTCTTGATCAAGGCGCTCATCGACCAAGGCTACATGAAACAAATCCTCGTTTCGAAT
GACTGGCTGTTCGGGTTTTCGAGCTATGTCACCAACATCATGGACGTGATGGATCGCGTG
AACCCCGACGGGATGGCCTTCATTCCACTGAGAGTGATCCCATTCCTACGAGAGAAGGGC
GTCCCACAGGAAACGCTGGCAGGCATCACTGTGACTAACCCGGCGCGGTTCTTGTCACCG
ACCTTGCGGGCGTCATGA

# Drug_Target_1_General_Function:
Involved in zinc ion binding

# Drug_Target_1_General_References:
2556372	Mulbry WW, Karns JS: Parathion hydrolase specified by the Flavobacterium opd gene: relationship between the gene and protein. J Bacteriol. 1989 Dec;171(12):6740-6.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2796

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
39004

# Drug_Target_1_Name:
Parathion hydrolase

# Drug_Target_1_Number_of_Residues:
365

# Drug_Target_1_PDB_ID:
1PSC

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02126	PTE

# Drug_Target_1_Protein_Sequence:
>Parathion hydrolase precursor
MQTRRVVLKSAAAAGTLLGGLAGCASVAGSIGTGDRINTVRGPITISEAGFTLTHEHICG
SSAGFLRAWPEFFGSRKALAEKAVRGLRRARAAGVRTIVDVSTFDIGRDVSLLAEVSRAA
DVHIVAATGLWFDPPLSMRLRSVEELTQFFLREIQYGIEDTGIRAGIIKVATTGKATPFQ
ELVLKAAARASLATGVPVTTHTAASQRDGEQQAAIFESEGLSPSRVCIGHSDDTDDLSYL
TALAARGYLIGLDHIPHSAIGLEDNASASALLGIRSWQTRALLIKALIDQGYMKQILVSN
DWLFGFSSYVTNIMDVMDRVNPDGMAFIPLRVIPFLREKGVPQETLAGITVTNPARFLSP
TLRAS

# Drug_Target_1_Reaction:
an aryl dialkyl phosphate + H2O = dialkyl phosphate + an aryl alcohol

# Drug_Target_1_Signals:
1-29

# Drug_Target_1_Specific_Function:
Has an unusual substrate specificity for synthetic organophosphate triesters and phosphorofluoridates. All of the phosphate triesters found to be substrates are synthetic compounds. The identity of any naturally occurring substrate for the enzyme is unknown. Has no detectable activity with phosphate monoesters or diesters and no activity as an esterase or protease. It catalyzes the hydrolysis of the insecticide paraoxon at a rate approaching the diffusion limit and thus appears to be optimally evolved for utilizing this synthetic substrate

# Drug_Target_1_SwissProt_ID:
P0A433

# Drug_Target_1_SwissProt_Name:
OPD_FLAS2

# Drug_Target_1_Synonyms:
EC 3.1.8.1
PTE
Parathion hydrolase precursor
Phosphotriesterase

# Drug_Target_1_Theoretical_pI:
8.48

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cell membrane

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
M20392

# Drug_Target_2_GenBank_ID_Protein:
151518

# Drug_Target_2_GeneCard_ID:
opd

# Drug_Target_2_Gene_Name:
opd

# Drug_Target_2_Gene_Sequence:
>978 bp
GTAAGCAATCGCAAGGGGGCAGCATGCAAACGAGAAGGGTTGTGCTCAAGTCTGCGGCCG
CGAGAACTCTGCTCGGCGGCCTGGCTGGGTGCGCGACGTGGCTGGATCGATCGGCACAGG
CGATGCGATCAATACGTGCGCGTCCTATCACAATCTCTGAAGCGGGTTTCACACTGACTC
ACGAGGACATCTCGGCAGCTCGGCAGGATTCTTGCGTGCTTGGCCAGAGTTCTTCGGTAG
CGCAAAGCTCTAGCGGAAAAGGCTGTGAGAGGATTGCGCGCCAGAGCGGCTGGCGTGCGA
ACGATTGTCGATGTGTCGACTTTCGATATCGGTCGCGACGTCAGTTTATTGGCCGAGGTT
TCGCGGGCTGCCGACGTTCATATCTGGCGGCGACCGGCTTGTGGTTCGACCCGCCACTTT
CGATGCGATTGAGGTATGTAGAGGAACTCACACTAGTTCTTCCTGCGGTGAGATTCAATA
TGGCATCGAAGTACACCGGAATTAGGGCGGGCATTATCAAGGTCGCGACCACAGGCAAGG
CGACCCCCTTTCAGGAGTTAGTGTTAAAGGCGGCCGCCCGGGCCAGCTTGGCCACCGGTG
TTCCGGTAACCACTCACACGGCAGCAAGTCAGCGCGATGGTGAGCGAGGCAGGCCGCCAT
TTTTGAGTCCGAAGCTTGAGCCCTCACGGGTTTGTATTGGTCACAGCGATGATACTGACG
ATTTGAGCTATCTCACCGCCCTGCTGCGCGGATACCTCATCGGTCTAGACCACATCCCGC
ACAGTGCGATTGGTCTAGAAGATAATGCGAGTGCATCACCGCTCCTGGGCATCCGTTCGT
GGCAAACACGGGCTCTCTTGATCAAGGCGCTCATCGACCAAGGCTACATGAAACAAATCC
TCGTTTCGAATGACTGGCTGTTCGGGTTTTCGAGCTATGTCACCAACATCATGGACGTGA
TGGATCGCGTGAACCCCG

# Drug_Target_2_General_Function:
Involved in aryldialkylphosphatase activity

# Drug_Target_2_General_References:
2834339	McDaniel CS, Harper LL, Wild JR: Cloning and sequencing of a plasmid-borne gene (opd) encoding a phosphotriesterase. J Bacteriol. 1988 May;170(5):2306-11.
7794910	Benning MM, Kuo JM, Raushel FM, Holden HM: Three-dimensional structure of the binuclear metal center of phosphotriesterase. Biochemistry. 1995 Jun 27;34(25):7973-8.
7999757	Benning MM, Kuo JM, Raushel FM, Holden HM: Three-dimensional structure of phosphotriesterase: an enzyme capable of detoxifying organophosphate nerve agents. Biochemistry. 1994 Dec 20;33(50):15001-7.
8155644	Kuo JM, Raushel FM: Identification of the histidine ligands to the binuclear metal center of phosphotriesterase by site-directed mutagenesis. Biochemistry. 1994 Apr 12;33(14):4265-72.
8634243	Vanhooke JL, Benning MM, Raushel FM, Holden HM: Three-dimensional structure of the zinc-containing phosphotriesterase with the bound substrate analog diethyl 4-methylbenzylphosphonate. Biochemistry. 1996 May 14;35(19):6020-5.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6539

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
39003.2

# Drug_Target_2_Name:
Parathion hydrolase

# Drug_Target_2_Number_of_Residues:
365

# Drug_Target_2_PDB_ID:
1PSC

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF02126	PTE

# Drug_Target_2_Protein_Sequence:
>Parathion hydrolase
MQTRRVVLKSAAAAGTLLGGLAGCASVAGSIGTGDRINTVRGPITISEAGFTLTHEHICG
SSAGFLRAWPEFFGSRKALAEKAVRGLRRARAAGVRTIVDVSTFDIGRDVSLLAEVSRAA
DVHIVAATGLWFDPPLSMRLRSVEELTQFFLREIQYGIEDTGIRAGIIKVATTGKATPFQ
ELVLKAAARASLATGVPVTTHTAASQRDGEQQAAIFESEGLSPSRVCIGHSDDTDDLSYL
TALAARGYLIGLDHIPHSAIGLEDNASASALLGIRSWQTRALLIKALIDQGYMKQILVSN
DWLFGFSSYVTNIMDVMDRVNPDGMAFIPLRVIPFLREKGVPQETLAGITVTNPARFLSP
TLRAS

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
1-29

# Drug_Target_2_Specific_Function:
Has an unusual substrate specificity for synthetic organophosphate triesters and phosphorofluoridates. All of the phosphate triesters found to be substrates are synthetic compounds. The identity of any naturally occurring substrate for the enzyme is unknown. Has no detectable activity with phosphate monoesters or diesters and no activity as an esterase or protease. It catalyzes the hydrolysis of the insecticide paraoxon at a rate approaching the diffusion limit and thus appears to be optimally evolved for utilizing this synthetic substrate

# Drug_Target_2_SwissProt_ID:
P0A434

# Drug_Target_2_SwissProt_Name:
OPD_BREDI

# Drug_Target_2_Synonyms:
PTE
Phosphotriesterase

# Drug_Target_2_Theoretical_pI:
8.48

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB02127
